Exploring drivers of self-treatment with antibiotics in three agricultural communities of northern Tanzania.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
29 Aug 2024
Historique:
received: 04 08 2023
accepted: 20 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Antimicrobial resistance (AMR) poses a significant global health threat, particularly in low- and middle-income countries (LMICs). Self-treatment with antibiotics, the practice of using antibiotics without professional guidance, is often considered an important contributor to the emergence and spread of AMR. This study investigated the drivers of self-treatment in three common types of agricultural communities in northern Tanzania. The research employed a comprehensive array of methods, including cross-sectional surveys (n = 790), interviews (n = 30) and observations (n = 178) targeting both antibiotic (human and animal) providers and users (patients and farmers). Qualitative interview data were analysed using a coding and association matrix, while descriptive analyses were performed on survey and observation data. Self-treatment with antibiotics was highly prevalent in all communities. Between 41.0% (self-reported) and 60.3% (observed) of human antibiotics were obtained without a prescription and we observed that veterinary antibiotics were regularly purchased in retail shops without referral by a professional. Structural deficiencies in the healthcare system drove this practice: limited access to healthcare facilities, medication stockouts and prolonged waiting times were identified as key factors. The absence of safety nets like insurance schemes further contributed to self-medication. Retail shops offered a convenient and cost-effective alternative when antibiotics were inaccessible or unaffordable. Notably, informal networks comprising treatment vendors, friends or neighbours, as well as personal experiences played a crucial role in guiding individuals in their self-treatment decisions by providing advice on treatment choice and modalities. Addressing self-treatment requires a multi-faceted approach. Improving the availability and accessibility of antibiotics, enhancing healthcare services and involving retail vendors in antibiotic stewardship are essential. Structural issues like access to diagnostics and medicines must be tackled, alongside reducing barriers and incentivising individuals to use professional healthcare services. Training retail vendors to sell specific first-line antibiotics over the counter with guidance on appropriate usage should be considered. Such bottom-up interventions will enable sustainable promotion of responsible antibiotic use, mitigating AMR emergence and securing a healthier future for all.

Sections du résumé

BACKGROUND BACKGROUND
Antimicrobial resistance (AMR) poses a significant global health threat, particularly in low- and middle-income countries (LMICs). Self-treatment with antibiotics, the practice of using antibiotics without professional guidance, is often considered an important contributor to the emergence and spread of AMR.
METHOD METHODS
This study investigated the drivers of self-treatment in three common types of agricultural communities in northern Tanzania. The research employed a comprehensive array of methods, including cross-sectional surveys (n = 790), interviews (n = 30) and observations (n = 178) targeting both antibiotic (human and animal) providers and users (patients and farmers). Qualitative interview data were analysed using a coding and association matrix, while descriptive analyses were performed on survey and observation data.
RESULTS RESULTS
Self-treatment with antibiotics was highly prevalent in all communities. Between 41.0% (self-reported) and 60.3% (observed) of human antibiotics were obtained without a prescription and we observed that veterinary antibiotics were regularly purchased in retail shops without referral by a professional. Structural deficiencies in the healthcare system drove this practice: limited access to healthcare facilities, medication stockouts and prolonged waiting times were identified as key factors. The absence of safety nets like insurance schemes further contributed to self-medication. Retail shops offered a convenient and cost-effective alternative when antibiotics were inaccessible or unaffordable. Notably, informal networks comprising treatment vendors, friends or neighbours, as well as personal experiences played a crucial role in guiding individuals in their self-treatment decisions by providing advice on treatment choice and modalities.
CONCLUSIONS CONCLUSIONS
Addressing self-treatment requires a multi-faceted approach. Improving the availability and accessibility of antibiotics, enhancing healthcare services and involving retail vendors in antibiotic stewardship are essential. Structural issues like access to diagnostics and medicines must be tackled, alongside reducing barriers and incentivising individuals to use professional healthcare services. Training retail vendors to sell specific first-line antibiotics over the counter with guidance on appropriate usage should be considered. Such bottom-up interventions will enable sustainable promotion of responsible antibiotic use, mitigating AMR emergence and securing a healthier future for all.

Identifiants

pubmed: 39210436
doi: 10.1186/s13756-024-01453-x
pii: 10.1186/s13756-024-01453-x
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94

Subventions

Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Medical Research Council, a Council of UK Research and Innovation
ID : MRC/AMR/ MR/S004815/1
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P007767/1
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

O’Neill J. Tackling drug-resistant infections globally: Final report and recommendations. London: HM Government and The Wellcome Trust; 2016. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
IACG. No time to wait: securing the future from drug-resistant infections. Report to the Secretary-General of the United Nations. Interagency Coordination Group on Antimicrobial Resistance; 2019.
Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci. 2015;112(18):5649–54.
pubmed: 25792457 pmcid: 4426470 doi: 10.1073/pnas.1503141112
Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018. https://doi.org/10.1073/pnas.1717295115 .
doi: 10.1073/pnas.1717295115 pubmed: 30591566 pmcid: 6338876
Loosli K, Davis A, Muwonge A, Lembo T. Addressing antimicrobial resistance by improving access and quality of care—a review of the literature from East Africa. PLoS Negl Trop Dis. 2021. https://doi.org/10.1371/journal.pntd.0009529 .
doi: 10.1371/journal.pntd.0009529 pubmed: 34292932 pmcid: 8297743
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55.
doi: 10.1016/S0140-6736(21)02724-0
World Bank. Drug-Resistant Infections: A Threat to Our Economic Future. Washington, D.C.: The World Bank; 2017. https://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf
United Republic of Tanzania. The National Action Plan on Antimicrobial Resistance 2023 - 2028. Dar es Salaam, Tanzania: Ministry of Health Tanzania; 2022. https://www.mifugouvuvi.go.tz/uploads/publications/sw1679278889-TANZANIA%20ANTIMICROBIAL%20RESISTANCE%20NATIONAL%20ACTION%20PLAN%202023%20-2028.pdf
UN Statistical Commission. Global Indicator Framework for the Sustainable Development Goals and Targets of the 2030 Agenda for Sustainable Development. UN Statistical Commission 2017; p. 1–21.
Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692–701.
pubmed: 21659004 pmcid: 3543997 doi: 10.1016/S1473-3099(11)70054-8
Belachew SA, Hall L, Selvey LA. Non-prescription dispensing of antibiotic agents among community drug retail outlets in Sub-Saharan African countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2021;10(1):13.
pubmed: 33446266 pmcid: 7807893 doi: 10.1186/s13756-020-00880-w
Yeika EV, Ingelbeen B, Kemah B, Wirsiy FS, Fomengia JN, Sande MAB. Comparative assessment of the prevalence, practices and factors associated with self-medication with antibiotics in Africa. Trop Med Int Health. 2021;26(8):862–81.
pubmed: 33942448 doi: 10.1111/tmi.13600
Caudell MA, Dorado-Garcia A, Eckford S, Creese C, Byarugaba DK, Afakye K, et al. Towards a bottom-up understanding of antimicrobial use and resistance on the farm: a knowledge, attitudes, and practices survey across livestock systems in five African countries. PLoS ONE. 2020;15(1):1–26.
doi: 10.1371/journal.pone.0220274
Mabilika RJ, Mpolya E, Shirima G. Prevalence and predictors of self-medication with antibiotics in selected urban and rural districts of the Dodoma region, Central Tanzania: a cross-sectional study. Antimicrob Resist Infect Control. 2022;11(1):86.
pubmed: 35710452 pmcid: 9205028 doi: 10.1186/s13756-022-01124-9
Virhia J, Gilmour M, Russell C, Mutua E, Nasuwa F, Mmbaga BT, et al. “If you do not take the medicine and complete the dose…It could cause you more trouble”: bringing awareness, local knowledge and experience into antimicrobial stewardship in Tanzania. Antibiotics. 2023;12(2):243.
pubmed: 36830154 pmcid: 9952761 doi: 10.3390/antibiotics12020243
Rutta E, Kibassa B, McKinnon B, Liana J, Mbwasi R, Mlaki W, et al. Increasing access to subsidized artemisinin-based combination therapy through accredited drug dispensing outlets in Tanzania. Health Res Policy Syst. 2011;9:22.
pubmed: 21658259 pmcid: 3141785 doi: 10.1186/1478-4505-9-22
Goodman CA, Kachur SP, Abdulla S, Bloland P, Mills A. Regulating Tanzania’s drug shops—Why do they break the rules, and does it matter? Health Policy Plan. 2007;22(6):393–403.
pubmed: 17921151 doi: 10.1093/heapol/czm033
Nkinda L, Kilonzi M, Felix FF, Mutagonda R, Myemba DT, Mwakawanga DL, et al. Drivers of irrational use of antibiotics among children: a mixed-method study among prescribers and dispensers in Tanzania. BMC Health Serv Res. 2022;22(1):961.
pubmed: 35902955 pmcid: 9335991 doi: 10.1186/s12913-022-08359-7
Higham LE, Ongeri W, Asena K, Thrusfield MV. Characterising and comparing animal-health services in the Rift Valley, Kenya: an exploratory analysis (part I). Trop Anim Health Prod. 2016;48(8):1621–32.
pubmed: 27614894 doi: 10.1007/s11250-016-1136-0
Rehman M, Ahmed S, Ahmed U, Tamanna K, Sabir MS, Niaz Z, et al. An overview of self-medication: a major cause of antibiotic resistance and a threat to global public health. J Pak Med Assoc. 2020;71:943–9.
Green DL, Keenan K, Fredricks KJ, Huque SI, Mushi MF, Kansiime C, et al. The role of multidimensional poverty in antibiotic misuse: a mixed-methods study of self-medication and non-adherence in Kenya, Tanzania, and Uganda. Lancet Glob Health. 2023;11(1):e59-68.
pubmed: 36521953 doi: 10.1016/S2214-109X(22)00423-5
Nthambi M, Lembo T, Davis A, Nasuwa F, Mmbaga BT, Matthews L, et al. Quantifying farmers’ preferences for antimicrobial use for livestock diseases in northern Tanzania. Q Open. 2023;3(1):qoac032.
doi: 10.1093/qopen/qoac032
Dixon J, MacPherson EE, Nayiga S, Manyau S, Nabirye C, Kayendeke M, et al. Antibiotic stories: a mixed-methods, multi-country analysis of household antibiotic use in Malawi, Uganda and Zimbabwe. BMJ Glob Health. 2021;6(11):1–15.
doi: 10.1136/bmjgh-2021-006920
Caudell MA, Quinlan MB, Subbiah M, Call DR, Roulette CJ, Roulette JW, et al. Antimicrobial use and veterinary care among agro-pastoralists in Northern Tanzania. PLoS ONE. 2017;12(1):1–18.
doi: 10.1371/journal.pone.0170328
Mboya EA, Sanga LA, Ngocho JS. Irrational use of antibiotics in the moshi municipality Northern Tanzania: a cross sectional study. Pan Afr Med J. 2018;31:1–10.
doi: 10.11604/pamj.2018.31.165.15991
Simon B, Kazaura M. Prevalence and factors associated with parents self-medicating under-fives with antibiotics in Bagamoyo District Council, Tanzania: a Cross-Sectional Study. Patient Prefer Adherence. 2020;14:1445–53.
pubmed: 32884246 pmcid: 7443408 doi: 10.2147/PPA.S263517
Embrey M, Vialle-Valentin C, Dillip A, Kihiyo B, Mbwasi R, Semali IA, et al. Understanding the role of accredited drug dispensing outlets in Tanzania’s Health System. PLoS ONE. 2016;11(11):e0164332.
pubmed: 27824876 pmcid: 5100953 doi: 10.1371/journal.pone.0164332
Chalker JC, Vialle-Valentin C, Liana J, Mbwasi R, Semali IA, Kihiyo B, et al. What roles do accredited drug dispensing outlets in Tanzania play in facilitating access to antimicrobials? Results of a multi-method analysis. Antimicrob Resist Infect Control. 2015;4(1):1–11.
doi: 10.1186/s13756-015-0075-2
Davis A, Virhia J, Buza J, Crump JA, de Glanville WA, Halliday JEB, et al. “He Who Relies on His Brother’s Property Dies Poor”: the complex narratives of livestock care in Northern Tanzania. Front Vet Sci. 2021;3(8):749561.
doi: 10.3389/fvets.2021.749561
Mangesho PE, Caudell MA, Mwakapeje ER, Ole-Neselle M, Kabali E, Obonyo M, et al. “We are doctors”: drivers of animal health practices among Maasai pastoralists and implications for antimicrobial use and antimicrobial resistance. Prev Vet Med. 2021;188:105266.
pubmed: 33517159 doi: 10.1016/j.prevetmed.2021.105266
Caudell M, Mangesho PE, Mwakapeje ER, Dorado-García A, Kabali E, Price C, et al. Narratives of veterinary drug use in northern Tanzania and consequences for drug stewardship strategies in low-income and middle-income countries. BMJ Glob Health. 2022;7(1):e006958.
pubmed: 35058305 pmcid: 8772431 doi: 10.1136/bmjgh-2021-006958
Davis A, Lembo T, Laurie E, Mutua E, Loosli K, Nthambi M, et al. How public health crises expose systemic, day-to-day health inequalities in low- and-middle income countries: an example from East Africa. Antimicrob Resist Infect Control. 2022;11(1):1–13.
doi: 10.1186/s13756-022-01071-5
Baltenweck I, Enahoro D, Frija A, Tarawali S. Why Is production of animal source foods important for economic development in Africa and Asia? Anim Front. 2020;10(4):22–9.
pubmed: 33150008 pmcid: 7596802 doi: 10.1093/af/vfaa036
Azabo R, Mshana S, Matee M, Kimera SI. Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC Vet Res. 2022;18(1):7.
pubmed: 34980101 pmcid: 8722348 doi: 10.1186/s12917-021-03056-9
Sindato C, Mboera LEG, Katale BZ, Frumence G, Kimera S, Clark TG, et al. Knowledge, attitudes and practices regarding antimicrobial use and resistance among communities of Ilala, Kilosa and Kibaha districts of Tanzania. Antimicrob Resist Infect Control. 2020;9(1):194.
pubmed: 33287878 pmcid: 7720393 doi: 10.1186/s13756-020-00862-y
Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis. 2013;56(10):1445–50.
pubmed: 23403172 doi: 10.1093/cid/cit070
Caudell MA, Mair C, Subbiah M, Matthews L, Quinlan RJ, Quinlan MB, et al. Identification of risk factors associated with carriage of resistant Escherichia coli in three culturally diverse ethnic groups in Tanzania: a biological and socioeconomic analysis. Lancet Planet Health. 2018;2(11):e489–97.
pubmed: 30396440 pmcid: 6215761 doi: 10.1016/S2542-5196(18)30225-0
Myers J, Hennessey M, Arnold JC, McCubbin KD, Lembo T, Mateus A, et al. Crossover-use of human antibiotics in livestock in agricultural communities: a qualitative cross-country comparison between Uganda, Tanzania and India. Antibiotics. 2022;11(10):1342.
pubmed: 36290000 pmcid: 9598773 doi: 10.3390/antibiotics11101342
Obrist B, Iteba N, Lengeler C, Makemba A, Mshana C, Nathan R, et al. Access to health care in contexts of livelihood insecurity: A framework for analysis and action. PLoS Med. 2007;4(10):1584–8.
pubmed: 17958467 doi: 10.1371/journal.pmed.0040308
de Glanville WA, Davis A, Allan KJ, Buza J, Claxton JR, Crump JA, et al. Classification and characterisation of livestock production systems in northern Tanzania. PLoS ONE. 2020;15(12):e0229478.
pubmed: 33378382 pmcid: 7773236 doi: 10.1371/journal.pone.0229478
Ahmed H, Call DR, Quinlan RJ, Yoder JK. Relationships between livestock grazing practices, disease risk, and antimicrobial use among East African Agropastoralists. Environ Dev Econ. 2018;23(1):80–97.
doi: 10.1017/S1355770X17000341
Dixon J, MacPherson E, Manyau S, Nayiga S, Khine Zaw Y, Kayendeke M, et al. The ‘Drug Bag’ method: lessons from anthropological studies of antibiotic use in Africa and South-East Asia. Glob Health Action. 2019. https://doi.org/10.1080/16549716.2019.1639388 .
doi: 10.1080/16549716.2019.1639388 pubmed: 31339473 pmcid: 6711116
Kawulich BB. Collecting data through observation. In: Doing Social Research: A global context. London: McGraw Hill; https://www.researchgate.net/publication/257944783_Collecting_data_through_observation
R core team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2022. https://www.R-project.org/
QSR International Pty Ltd. Nvivo 12. QSR International Pty Ltd; 2018. https://support.qsrinternational.com/nvivo/s/
Muleme J, Kankya C, Ssempebwa JC, Mazeri S, Muwonge A. A Framework for integrating qualitative and quantitative data in knowledge, attitude, and practice studies: a case study of pesticide usage in Eastern Uganda. Front Public Health. 2017;8(5):318.
doi: 10.3389/fpubh.2017.00318
WHO. WHO Access, Watch, Reserve (AWaRe) classification of antibiotics for evaluation and monitoring of use. World Health Organization; 2021. https://www.who.int/publications-detail-redirect/2021-aware-classification
EMA. Categorisation of antibiotics for use in animals. European Medicines Agency; 2019.
Mdegala RH, Mwakapeje ER, Rubegqa B, Gebeyehu DT, Niyigena S, Msambichaka V, et al. Antimicrobial use, residues, resistance and Governance in the food and agriculture sectors, Tanzania. Antibiotics. 2021;10:2020120632.
Horumpende PG, Said SH, Mazuguni FS, Antony ML, Kumburu HH, Sonda TB, et al. Prevalence, determinants and knowledge of antibacterial self-medication: a cross sectional study in North-eastern Tanzania. PLoS ONE. 2018;13(10):e0206623.
pubmed: 30379961 pmcid: 6209340 doi: 10.1371/journal.pone.0206623
Emgård M, Mwangi R, Mayo C, Mshana E, Nkini G, Andersson R, et al. Antibiotic use in children under 5 years of age in Northern Tanzania: a qualitative study exploring the experiences of the caring mothers. Antimicrob Resist Infect Control. 2022;11(1):130.
pubmed: 36329551 pmcid: 9630810 doi: 10.1186/s13756-022-01169-w
Hetzel MW, Iteba N, Makemba A, Mshana C, Lengeler C, Obrist B, et al. Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Malar J. 2007;6:1–15.
doi: 10.1186/1475-2875-6-83
McCubbin KD, Ramatowski JW, Buregyeya E, Hutchinson E, Kaur H, Mbonye AK, et al. Unsafe “crossover-use” of chloramphenicol in Uganda: importance of a One Health approach in antimicrobial resistance policy and regulatory action. J Antibiot (Tokyo). 2021;74:417–20.
pubmed: 33742170 doi: 10.1038/s41429-021-00416-3
Dillip A, Embrey M, Shekalaghe E, Ross-Degnan D, Vialle-Valentin C, Kimatta S, et al. What motivates antibiotic dispensing in accredited drug dispensing outlets in Tanzania? A qualitative study. Antimicrob Resist Infect Control. 2015;4(1):30.
pubmed: 26199723 pmcid: 4509560 doi: 10.1186/s13756-015-0073-4
Valimba R, Liana J, Joshi MP, Rutta E, Embrey M, Bundala M, et al. Engaging the private sector to improve antimicrobial use in the community: experience from accredited drug dispensing outlets in Tanzania. J Pharm Policy Pract. 2014;7(1):11.
pubmed: 25298887 pmcid: 4177420 doi: 10.1186/2052-3211-7-11
Meyer JC, Schellack N, Stokes J, Lancaster R, Zeeman H, Defty D, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; A preliminary study. Front Pharmacol. 2017;8:1–16.
doi: 10.3389/fphar.2017.00751
Chigome AK, Matlala M, Godman B, Meyer JC. Availability and use of therapeutic interchange policies in managing antimicrobial shortages among South African public sector hospitals; findings and implications. Antibiotics. 2020;9(1):1–11.
Do NTT, Vu HTL, Nguyen CTK, Punpuing S, Khan WA, Gyapong M, et al. Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach. Lancet Glob Health. 2021;9(5):e610–9.
pubmed: 33713630 pmcid: 8050200 doi: 10.1016/S2214-109X(21)00024-3
Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019;4(6):e002104.
pubmed: 31799007 pmcid: 6861125 doi: 10.1136/bmjgh-2019-002104
Roulette CJ, Caudell MA, Roulette JW, Quinlan RJ, Quinlan MB, Subbiah M, et al. A two-month follow-up evaluation testing interventions to limit the emergence and spread of antimicrobial resistant bacteria among Maasai of northern Tanzania. BMC Infect Dis. 2017;17(1):1–10.
doi: 10.1186/s12879-017-2857-z
Davis A, Sharp J. Rethinking One Health: emergent human, animal and environmental assemblages. Soc Sci Med. 2020;258:113093.
pubmed: 32531688 pmcid: 7369629 doi: 10.1016/j.socscimed.2020.113093

Auteurs

Kathrin Loosli (K)

The Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK. Kathrin.Loosli@glasgow.ac.uk.

Fortunata Nasuwa (F)

Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

Matayo Melubo (M)

Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

Kunda Mnzava (K)

Department of Microbiology and Immunology, Catholic University of Health and Allied Sciences/Bugando Medical Centre, Mwanza, Tanzania.

Louise Matthews (L)

The Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.

Stephen E Mshana (SE)

Department of Microbiology and Immunology, Catholic University of Health and Allied Sciences/Bugando Medical Centre, Mwanza, Tanzania.

Blandina T Mmbaga (BT)

Kilimanjaro Clinical Research Institute/Kilimanjaro Christian Medical University College, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

Adrian Muwonge (A)

Digital One Health Laboratory, The Roslin Institute, The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush Campus, Edinburgh, UK.

Alicia Davis (A)

School of Social and Political Sciences and School of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Tiziana Lembo (T)

The Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH